MétaCan
Menu
Back to cohort
Record W2769938174 · doi:10.7326/l17-0477

Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus

2017· letter· en· W2769938174 on OpenAlexaboutno aff
Susan Bersoff‐Matcha, Kelly Cao, Mihaela Jason, S. Christopher Jones, Allen Brinker

Bibliographic record

VenueAnnals of Internal Medicine · 2017
Typeletter
Languageen
FieldMedicine
TopicHepatitis C virus research
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineFood and drug administrationVirologyHepatitis B virusHepatitis BChronic hepatitisVirusPharmacology

Abstract

fetched live from OpenAlex

Letters21 November 2017Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C VirusSusan J. Bersoff-Matcha, MD, Kelly Cao, PharmD, Mihaela Jason, PharmD, S. Christopher Jones, PharmD, MS, MPH, and Allen Brinker, MD, MSSusan J. Bersoff-Matcha, MDU.S. Food and Drug Administration, Silver Spring, Maryland (S.J.B., K.C., M.J., S.C.J., A.B.)Search for more papers by this author, Kelly Cao, PharmDU.S. Food and Drug Administration, Silver Spring, Maryland (S.J.B., K.C., M.J., S.C.J., A.B.)Search for more papers by this author, Mihaela Jason, PharmDU.S. Food and Drug Administration, Silver Spring, Maryland (S.J.B., K.C., M.J., S.C.J., A.B.)Search for more papers by this author, S. Christopher Jones, PharmD, MS, MPHU.S. Food and Drug Administration, Silver Spring, Maryland (S.J.B., K.C., M.J., S.C.J., A.B.)Search for more papers by this author, and Allen Brinker, MD, MSU.S. Food and Drug Administration, Silver Spring, Maryland (S.J.B., K.C., M.J., S.C.J., A.B.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L17-0477 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:Dr. Mahale and colleagues postulate that HDV infection may have contributed to HBV reactivation in cases identified in our cohort. However, in our case series, there were no reports of HDV infection in either the U.S. Food and Drug Administration Adverse Event Reporting System database or the literature that we reviewed. A limitation of the database is that data may be missing, so we do not know whether results of serologic testing for HDV infection were negative or whether testing was not done. Therefore, we cannot exclude HDV co-infection as a contributing factor in HBV reactivation from the ...Reference1. Infectious Diseases Society of America/American Association for the Study of Liver Diseases. Recommendations for testing, managing, and treating hepatitis C. 2015. Accessed at http://hcvguidelines.org on 20 July 2017. Google Scholar Author, Article, and Disclosure InformationAffiliations: U.S. Food and Drug Administration, Silver Spring, Maryland (S.J.B., K.C., M.J., S.C.J., A.B.)Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-0377. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoHepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System Susan J. Bersoff-Matcha , Kelly Cao , Mihaela Jason , Adebola Ajao , S. Christopher Jones , Tamra Meyer , and Allen Brinker Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Parag Mahale , Jeffrey S. Glenn , and Thomas R. O’Brien Metrics Cited byHepatitis B surface antibody titres and hepatitis B reactivation with direct‐acting antiviral therapy for hepatitis CCare quality and outcomes among US veterans with chronic hepatitis B in the hepatitis C direct‐acting antiviral eraKidney disease in patients with chronic liver diseaseSummary of the 2018 Kidney Disease Improving Global Outcomes (KDIGO) Guideline on hepatitis C in chronic kidney diseaseReal-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patients 21 November 2017Volume 167, Issue 10Page: 760KeywordsAntiviral therapyDatabasesHepatitis BHepatitis virusesInfectious diseasesInfectious hepatitisLiver diseasesMedical risk factorsPatientsTreatment guidelines ePublished: 21 November 2017 Issue Published: 21 November 2017 Copyright & PermissionsCopyright © 2017 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.011
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Editorial · Consensus signal: none
Teacher disagreement score0.055
Threshold uncertainty score0.183

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.011
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0020.003
Science and technology studies0.0000.000
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0020.001
Insufficient payload (model declined to judge)0.0550.007

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.098
GPT teacher head0.393
Teacher spread0.295 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEditorial

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations8
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueAnnals of Internal MedicineSame topicHepatitis C virus researchFrench-language works237,207